- Home
- MBOT vs CVRX Comparison
MBOT vs CVRX Comparison
Compare MBOT & CVRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBOT
- CVRX
- Stock Information
- Founded
- MBOT 2010
- CVRX 2000
- Country
- MBOT United States
- CVRX United States
- Employees
- MBOT N/A
- CVRX N/A
- Industry
- MBOT Medical/Dental Instruments
- CVRX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MBOT Health Care
- CVRX Health Care
- Exchange
- MBOT Nasdaq
- CVRX Nasdaq
- Market Cap
- MBOT 184.8M
- CVRX 203.9M
- IPO Year
- MBOT N/A
- CVRX 2021
- Fundamental
- Price
- MBOT $3.42
- CVRX $6.92
- Analyst Decision
- MBOT Strong Buy
- CVRX Buy
- Analyst Count
- MBOT 1
- CVRX 7
- Target Price
- MBOT $12.00
- CVRX $14.00
- AVG Volume (30 Days)
- MBOT 6.9M
- CVRX 178.7K
- Earning Date
- MBOT 11-12-2025
- CVRX 10-28-2025
- Dividend Yield
- MBOT N/A
- CVRX N/A
- EPS Growth
- MBOT N/A
- CVRX N/A
- EPS
- MBOT N/A
- CVRX N/A
- Revenue
- MBOT N/A
- CVRX $54,652,000.00
- Revenue This Year
- MBOT N/A
- CVRX $11.32
- Revenue Next Year
- MBOT $728.02
- CVRX $18.58
- P/E Ratio
- MBOT N/A
- CVRX N/A
- Revenue Growth
- MBOT N/A
- CVRX 23.11
- 52 Week Low
- MBOT $0.85
- CVRX $4.30
- 52 Week High
- MBOT $4.67
- CVRX $18.55
- Technical
- Relative Strength Index (RSI)
- MBOT 48.25
- CVRX 39.52
- Support Level
- MBOT $3.54
- CVRX $7.22
- Resistance Level
- MBOT $4.25
- CVRX $8.35
- Average True Range (ATR)
- MBOT 0.44
- CVRX 0.43
- MACD
- MBOT -0.05
- CVRX -0.05
- Stochastic Oscillator
- MBOT 13.79
- CVRX 3.38
About MBOT Microbot Medical Inc.
Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.
About CVRX CVRx Inc.
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.